Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery

• Status: Unknown status
• Trial end date: 2007-02-01
• Target enrollment: 0
• Participant gender: All

Summary

To study the activity of chemotherapy with Gemzar-carboplatin in the preoperative setting for operable stages of non-small-cell lung cancer and to identify novel molecular markers correlated with chemosensitivity and prognosis

• Phase: Phase 2

Details

• Lead Sponsor: Hospital Authority, Hong Kong
• Collaborator: Eli Lilly and Company
• Treatments: Carboplatin; Gemcitabine

Criteria

Inclusion Criteria:

• Histologically or cytologically proven, newly diagnosed primary bronchogenic non-small cell lung cancer

• Measurable or evaluable tumour on chest X-ray or CT scan.

• No multiple ipsilateral or contralateral parenchymal tumours

• Stage I(exceptT1N0),II,IIIa disease as shown by PET-CT